We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » U.S. FDA Has No ‘Inherent Authority’ to Reclassify, Appeals Court Rules
U.S. FDA Has No ‘Inherent Authority’ to Reclassify, Appeals Court Rules
The U.S. Food and Drug Administration’s authority to reconsider and rescind earlier classification decisions could be severely limited following a recent federal court ruling.
To View This Article:
Login
Subscribe To International Medical Device Regulatory Monitor